☆ 4.7 Editorial Material

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

期刊

JOURNAL FOR IMMUNOTHERAPY OF CANCER

卷 8, 期 1, 页码 -

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/jitc-2020-000878

关键词

immunomodulation; inflammation mediators

类别

Oncology Immunology

资金

NCI NIH HHS [R35 CA197078] Funding Source: Medline
NIEHS NIH HHS [P30 ES005605] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Immunology

A Next Generation Formulation of Curcumin Ameliorates Experimentally Induced Osteoarthritis in Rats via Regulation of Inflammatory Mediators

Mehmet Yabas, Cemal Orhan, Besir Er, Mehmet Tuzcu, Ali Said Durmus, Ibrahim Hanifi Ozercan, Nurhan Sahin, Prakash Bhanuse, Abhijeet Ashok Morde, Muralidhara Padigaru, Kazim Sahin

Summary: This study introduced a highly bioavailable formulation of curcumin, NGUC, which effectively ameliorated the pathophysiology of knee osteoarthritis in rats by restoring joint architecture, reducing inflammation, and oxidative stress. NGUC supplementation also decreased levels of inflammatory mediators and increased antioxidant enzyme levels in synovial tissue.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection

Nicolas Degauque, Alain Haziot, Sophie Brouard, Nuala Mooney

Summary: In the inflammation and infection caused by SARS-CoV-2, endothelial cells play a crucial role in regulating the recruitment of immune cells and interacting with monocytes, T cells, and B cells. Endothelial cells function as an integrative and active platform for immune responses, providing opportunities for therapeutic intervention.

FASEB JOURNAL (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases

Pablo Rayff da Silva, Renan Fernandes do Espirito Santo, Camila de Oliveira Melo, Fabio Emanuel Pachu Cavalcante, Thassia Borges Costa, Yasmim Vilarim Barbosa, Yvnni M. S. de Medeiros e Silva, Natalia Ferreira de Sousa, Cristiane Flora Villarreal, Ricardo Olimpio de Moura, Vanda Lucia dos Santos

Summary: The compound (E)-2-cyano-N,3-diphenylacrylamide (JMPR-01) shows strong anti-inflammatory potential and could be a potential drug for the treatment of inflammatory diseases.

PHARMACEUTICS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients

Mauricio Castillo-Salazar, Fausto Sanchez-Munoz, Rashidi Springall del Villar, Gabriel Navarrete-Vazquez, Adrian Hernandez-DiazCouder, Carlos Mojica-Cardoso, Sara Garcia-Jimenez, Cairo Toledano-Jaimes, German Bernal-Fernandez

Summary: The study demonstrated that nitazoxanide has immunomodulatory effects on peripheral blood mononuclear cells from patients with type 2 diabetes, inhibiting T lymphocyte proliferation, reducing various cytokine concentrations, and regulating the M1/M2 ratio through miRNA expression modulation.

BIOMOLECULES (2021)

添加到收藏夹

Article Food Science & Technology

Immunomodulatory effects of seed peptide lunasin in RAW264.7 macrophages in obese microenvironments

Pei-Ying Huang, Chia-Chien Hsieh

Summary: This study investigated the mechanism of lunasin in regulating immune functions of RAW264.7 macrophages under obesity-related conditions. The findings showed that lunasin protected the vitality of macrophages, suppressed leptin secretion, and reduced inflammation markers in LPS-stimulated co-culture. However, it had opposing effects in adipocyte-conditioned medium and co-culture without LPS. Additionally, lunasin enhanced phagocytosis in both LPS and adipocyte-conditioned medium challenges.

JOURNAL OF FUNCTIONAL FOODS (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod

Safura Pournajaf, Leila Dargahi, Mohammad Javan, Mohammad Hossein Pourgholami

Summary: Fingolimod is an effective therapy for disease progression, reducing T-cell numbers, suppressing inflammation, and potentially treating various pathological conditions. It modulates multiple molecular pathways and has shown potential therapeutic effects in immunomodulatory diseases, CNS injuries, Alzheimer's disease, Parkinson's disease, epilepsy, and cancer.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Nutrition & Dietetics

Effects of Whey Protein Supplementation on Inflammatory Marker Concentrations in Older Adults

Samuel Adler, Wyatt Olsen, Bryna Rackerby, Rachel Spencer, David C. Dallas

Summary: This study investigated the effects of whey protein isolate (WPI) supplementation on inflammatory markers in healthy older adults. The results showed that WPI supplementation did not significantly alter most inflammatory markers, but could alter the concentrations of some inflammatory markers.

NUTRIENTS (2023)

添加到收藏夹

Review Nutrition & Dietetics

Vitamin D, Its Role in Recovery after Muscular Damage Following Exercise

Alberto Caballero-Garcia, Alfredo Cordova-Martinez, Nestor Vicente-Salar, Enrique Roche, Daniel Perez-Valdecantos

Summary: Vitamin D plays a crucial role in immune modulation, enhancing macrophage functions and modulating muscle inflammatory response and protein synthesis. It is particularly important in cases of deficiency or high muscular demand.

NUTRIENTS (2021)

添加到收藏夹

Article Immunology

Methyldecanoate isolated from marine algae Turbinaria ornata enhances immunomodulation in LPS-induced inflammatory reactions in RAW 264.7 macrophages via iNOS/NF?B pathway

Meenakshi Bhardwaj, Veeresh Kumar Sali, R. Malarvizhi, Sugumar Mani, T. K. Padmavathy, Hannah Rachel Vasanthi

Summary: This study identifies a fatty acid methyl ester, methyl 6,12-dimethyltridecanoate (ET), isolated from the brown algae Turbinaria ornata, which possesses anti-inflammatory, antioxidant, and immunomodulatory potential. In vitro and in silico studies demonstrate the significant anti-inflammatory effects of ET, including the inhibition of inflammatory markers and the promotion of antioxidant enzymes. The findings establish a molecular basis for the anti-inflammatory properties of ET and its potential as a therapeutic agent.

INFLAMMOPHARMACOLOGY (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Therapeutic Application of Exosomes in Inflammatory Diseases

Ju Hun Suh, Hyeon Su Joo, Eun Be Hong, Hyeon Ji Lee, Jung Min Lee

Summary: Exosomes, as an advanced therapeutic strategy for treating an overactive immune system, are gaining attention and have the potential to be applied in the treatment of various inflammatory and autoimmune diseases, showing promising prospects for the future.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Food Science & Technology

Seed peptide lunasin ameliorates obesity-induced inflammation and regulates immune responses in C57BL/6J mice fed high-fat diet

Chia-Chien Hsieh, Yen-Fang Wang, Pin-Yu Lin, Shih-Han Peng, Mei-Jia Chou

Summary: The study revealed that lunasin can reduce inflammation levels in obese mice, decrease macrophage infiltration in adipose tissue, and regulate spleen size and cell numbers. Additionally, lunasin promotes the production of interferon gamma and interleukin-2 in splenocytes, thus modulating immune responses.

FOOD AND CHEMICAL TOXICOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

How do different bile acid derivatives affect rat macrophage function - Friends or foes?

Nikola M. Stojanovic, Pavle J. Randjelovic, Aleksandra Maslovaric, Milos Kostic, Vidak Raicevic, Marija Sakac, Srdan Bjedov

Summary: This study evaluated the immunomodulatory potential of a selected library of bile acid derivatives (BAD) and found that these substances can affect the function of macrophages and have anti-inflammatory effects within a certain concentration range.

CHEMICO-BIOLOGICAL INTERACTIONS (2023)

添加到收藏夹

Review Immunology

Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19

Vincent J. Venditto, Dalia Haydar, Ahmed Abdel-Latif, John C. Gensel, Michael I. Anstead, Michelle G. Pitts, Jarrod Creameans, Timothy J. Kopper, Chi Peng, David J. Feola

Summary: The rapid spread of COVID-19 has led to an increased focus on finding effective treatments, with many immunomodulatory therapies currently under investigation. Azithromycin, as an immunomodulatory drug, has potential benefits in late-stage treatment but also carries risks of immunosuppression and off-target effects.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation

Chiel van Geffen, Constantin Heiss, Astrid Deissler, Saeed Kolahian

Summary: In this article, we summarize and critically discuss different pharmacological approaches to modulate the generation, activation, and recruitment of MDSCs in vitro and in vivo, and their potential role in future immunosuppressive therapy.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Nanofiber-Based Delivery of Bioactive Lipids Promotes Pro-regenerative Inflammation and Enhances Muscle Fiber Growth After Volumetric Muscle Loss

Cheryl L. San Emeterio, Lauren A. Hymel, Thomas C. Turner, Molly E. Ogle, Emily G. Pendleton, William Y. York, Claire E. Olingy, Alan Y. Liu, Hong Seo Lim, Todd A. Sulchek, Gordon L. Warren, Luke J. Mortensen, Peng Qiu, Young C. Jang, Nick J. Willett, Edward A. Botchwey

Summary: Volumetric muscle loss (VML) is a significant clinical challenge after extremity trauma, and an immunomodulatory biomaterial therapy shows promise in addressing this issue. Modulating S1P receptor signaling can enhance muscle stem cell abundance and myofiber diameter, aiding in regeneration following VML injury.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

添加到收藏夹

Article Rheumatology

Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid Arthritis

Elizaveta Efuni, Samuel Cytryn, Patrick Boland, Timothy B. Niewold, Anna Pavlick, Jeffrey Weber, Sabina Sandigursky

Summary: The incidence of immune-related adverse events (irAEs) following ICI treatment in RA patients is not significantly higher compared to other cancer patients. RA disease activity may worsen during ICI treatment, but most adverse events can be managed with oral corticosteroids, and only a few cases require permanent ICI discontinuation. Collaboration between oncologists and rheumatologists is recommended when considering the use of ICIs in RA patients.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)

添加到收藏夹

Article Oncology

The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trials

Roger Olofsson Bagge, Lars Ny, Paolo A. Ascierto, F. Stephen Hodi, James Larkin, Caroline Robert, Jacob Schachter, Jeffrey S. Weber, Georgina Long, Alexander C. J. van Akkooi

Summary: There is a lack of evidence from prospective clinical trials on the use of immunotherapy in patients with ITM. It is recommended to pool data from multiple institutions to examine the efficacy of available drug therapies in this patient population. More importantly, prospective clinical trials of locoregional treatments with or without systemic drug therapies are required.

MELANOMA RESEARCH (2021)

添加到收藏夹

Article Medicine, Research & Experimental

The Great Debate at Melanoma Bridge 2020: December, 5th, 2020

Paolo A. Ascierto, Michael B. Atkins, Alexander M. Eggermont, Jeffrey E. Gershenwald, Jean-Jacques Grob, Omid Hamid, Vernon K. Sondak, Jeffrey A. Sosman, Hussein A. Tawbi, Jeffrey S. Weber, Corrado Caraco, Iman Osman, Igor Puzanov

Summary: The Great Debate session at the 2020 Melanoma Bridge virtual congress featured counterpoint views from experts on five specific controversial issues in melanoma. The debates covered topics such as the importance of innate immunity, staging, treatment methods, showing differing opinions among experts.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Oncology

Presence of Tim3(+) and PD-1(+) CD8(+) T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and distinct clinicopathological features

Max Klapholz, Michael G. Drage, Amitabh Srivastava, Ana C. Anderson

Summary: Colorectal carcinoma (CRC) is the second leading cause of cancer mortality worldwide, with microsatellite stable (MSS) subtype being the majority and insensitive to immunotherapies. This study identified an immune exhausted CD8(+) TIL subset in MSS CRC patients, and suggested that targeting Tim-3 in combination with anti-PD-1 immunotherapy may be clinically beneficial.

JOURNAL OF PATHOLOGY (2022)

添加到收藏夹

Article Oncology

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Ahmad A. Tarhini, Sandra J. Lee, Aik-Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield, William A. LaFramboise, Walter J. Storkus, Arivarasan D. Karunamurthy, Jose R. Conejo-Garcia, Patrick Hwu, Howard Streicher, Vernon K. Sondak, John M. Kirkwood

Summary: Melanoma of unknown primary (MUP) has a significantly better prognosis and shows evidence of significantly enhanced immune activation within the tumor microenvironment and the circulation in high-risk melanoma patients.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Article Medicine, Research & Experimental

The future of cancer immunotherapy for brain tumors: a collaborative workshop

Christine E. Brown, Samantha Bucktrout, Lisa H. Butterfield, Olga Futer, Evanthia Galanis, Adilia Hormigo, Michael Lim, Hideho Okada, Robert Prins, Sara Siebel Marr, Kirk Tanner

Summary: Research and clinical trials on utilizing the immune system to fight brain tumors with specificity and memory have been ongoing for many years. Although progress has been made, obstacles such as the lack of representative animal models and efficient biopsy methods still exist.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Review Immunology

Immunomodulatory impact of α-fetoprotein

Paul V. Munson, Juraj Adamik, Lisa H. Butterfield

Summary: Alpha-fetoprotein (AFP) is a fetal glycoprotein produced by hepatocellular carcinoma tumors in humans. It plays an immunosuppressive role in pregnancy, autoimmunity, and cancer by limiting the functionality of natural killer cells, monocytes, and dendritic cells. Recent research has focused on the molecular characteristics of AFP and its impact on cellular metabolism.

TRENDS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Oncology

Hallmarks of Resistance to Immune-Checkpoint Inhibitors

Maria Karasarides, Alexandria P. Cogdill, Paul B. Robbins, Michaela Bowden, Elizabeth M. Burton, Lisa H. Butterfield, Alessandra Cesano, Christian Hammer, Cara L. Haymaker, Christine E. Horak, Heather M. McGee, Anne Monette, Nils-Petter Rudqvist, Christine N. Spencer, Randy F. Sweis, Benjamin G. Vincent, Erik Wennerberg, Jianda Yuan, Roberta Zappasodi, Vanessa M. Hubbard Lucey, Daniel K. Wells, Theresa LaVallee

Summary: This study systematically explores key nodes of immune resistance through the lens of known biological processes, providing support and guidance for future immune resistance research. Integration of multiomic high-dimensional analyses with patient data can help guide effective drug development strategies and improve patient outcomes.

CANCER IMMUNOLOGY RESEARCH (2022)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

Advancing T cell-based cancer therapy with single-cell technologies

Samantha L. Bucktrout, Nicholas E. Banovich, Lisa H. Butterfield, Cansu Cimen-Bozkus, Josephine R. Giles, Zinaida Good, Daniel Goodman, Vanessa D. Jonsson, Caleb Lareau, Alexander Marson, Denna M. Maurer, Paul Munson, Mike Stubbington, Sarah Taylor, Abbey Cutchin

Summary: This article summarizes a workshop organized by the Parker Institute of Cancer Immunotherapy and 10x Genomics, where researchers and innovators in T cell immunotherapy and single-cell technologies gathered to discuss the attributes of ideal therapeutic T cells and areas for future development. The goal of the workshop was to advance the understanding of T cell research and translate it into effective cancer immunotherapies.

NATURE MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells

Juraj Adamik, Paul Munson, Felix J. Hartmann, Alexis J. Combes, Philippe Pierre, Matthew F. Krummel, Sean C. Bendall, Rafael J. Arguello, Lisa H. Butterfield

Summary: Assessing metabolic activity at the single-cell level provides important insights into the immune profiles of human dendritic cells. This study reveals the metabolic differences between immune stimulatory and tolerogenic dendritic cells, and highlights the simultaneous engagement of multiple metabolic pathways in distinct stages of dendritic cell differentiation.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Oncology

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)

Michael B. Atkins, Hamzah Abu-Sbeih, Paolo A. Ascierto, Michael R. Bishop, Daniel S. Chen, Madhav Dhodapkar, Leisha A. Emens, Marc S. Ernstoff, Robert L. Ferris, Tim F. Greten, James L. Gulley, Roy S. Herbst, Rachel W. Humphrey, James Larkin, Kim A. Margolin, Luca Mazzarella, Suresh S. Ramalingam, Meredith M. Regan, Brian Rini, Mario Sznol

Summary: The activity of agents blocking PD-(L)1 axis has revolutionized oncology, but not all patients benefit from these therapies. Many drug development programs have combined anti-PD-(L)1 with other therapies, but there is a lack of predictive biomarkers and optimized clinical trial designs.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Article Oncology

Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade

Xiaoyu Li, Jingjing Li, Yue Zheng, Sandra J. Lee, Jun Zhou, Anita Giobbie-Hurder, Lisa H. Butterfield, Glenn Dranoff, F. Stephen Hodi

Summary: With the successful development of immune checkpoint blockade, the addition of granulocyte-macrophage-CSF (GM-CSF) has been shown to improve efficacy and decrease adverse events. The presence of ICOS+CD4+ or ICOS+CD8+ T cells in the peripheral blood is significantly higher in patients treated with ipilimumab plus GM-CSF compared to those treated with ipilimumab alone. Soluble ICOS splice variants have suppressive effects and can serve as a biomarker for GM-CSF and immune checkpoint blockade-based therapies.

CANCER IMMUNOLOGY RESEARCH (2023)

添加到收藏夹

Review Immunology

Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations

Lisa H. Butterfield, Yana G. Najjar

Summary: The approval of immune checkpoint inhibitors has shifted the treatment paradigm for malignancies. Combination therapies and biomarker studies are important for maximizing clinical efficacy.

NATURE REVIEWS IMMUNOLOGY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients

Juraj Adamik, Paul V. Munson, Deena M. Maurer, Felix J. Hartmann, Sean C. Bendall, Rafael J. Arguello, Lisa H. Butterfield

Summary: This study analyzed the transcriptomic and immune-metabolic profiles of dendritic cells (DCs) from patients with late-stage melanoma. The results suggest that the metabolic profile of DCs is associated with the immunostimulatory potential of cancer vaccines.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Review Oncology

Spatial determinants of CD8(+)T cell differentiation in cancer

Katherine A. Tooley, Giulia Escobar, Ana C. Anderson

Summary: This article focuses on the spatial determinants regulating CD8(+) T cell phenotypes and functions, highlighting the importance of new spatial transcriptomics and imaging technologies in uncovering mechanistic insights.

TRENDS IN CANCER (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.